Category: array

Generation of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 gene

Generation of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 geneGeneration of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 gene

Bartter Syndrome (BS) is a gaggle of uncommon inherited autosome-recessive illness, which might be attributable to the gene mutations of sodium-potassium-chloride cotransporter gene (SLC12A1). Right here, the urine cells (UCs)

S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.

S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.

Uterine carcinosarcoma (UCS) represents a real instance of most cancers related to epithelial-mesenchymal transition (EMT), which displays most cancers stem cell (CSC)-like traits. Though S100A4 is an inducer of EMT, little is

Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.

Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.

Antibody (Ab) fragments have nice medical potential as most cancers therapeutics and diagnostics. Their small measurement permits for quick clearance from blood, low immunoreactivity, higher tumor penetration, and less complicated

Vimseltinib: A precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophages

Vimseltinib: A precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophagesVimseltinib: A precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophages

Macrophages will be co-opted to contribute to neoplastic, neurologic, and inflammatory ailments. Colony stimulating issue 1 receptor (CSF1R)-dependent macrophages and different inflammatory cells can suppress the adaptive immune system in

Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity
Clinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantation

Clinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantationClinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantation

Continual energetic antibody-mediated rejection (CAAMR) is a frequent reason behind late graft loss. Nonetheless, efficient remedy for CAAMR after kidney transplantation has not but been established. Right here, we current